Get started
Author

Kilian B. Kennel

Observed names: Kilian B Kennel, Kilian Kennel
Institution: Georg Speyer Haus
ORCID: 0000-0002-7375-1249
Observed ORCID: 0000-0002-7375-1249
OpenAlex ID: A5066121565
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer
2022 · Adele M. Nicolas, Marina Pesic, et al. · Cancer Cell · 364
PDF
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
2022 · Kilian B. Kennel, Müge Bozlar, et al. · Clinical Cancer Research · 314
PDF
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
2023 · Claire Conche, Fabian Finkelmeier, et al. · Gut · 287
PDF
Immune cell - produced ROS and their impact on tumor growth and metastasis
2021 · Kilian B. Kennel, Florian R. Greten · Redox Biology · 213
PDF
Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2023 · Henner F. Farin, Mohammed H. Mosa, et al. · Cancer Discovery · 138
The immune microenvironment of colorectal cancer
2025 · Kilian B. Kennel, Florian R. Greten · Nature reviews. Cancer · 128
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation
2022 · Mark Schmitt, Fatih Ceteci, et al. · Nature · 105
Current and emerging concepts for systemic treatment of metastatic colorectal cancer
2025 · Christoph Steup, Kilian B Kennel, et al. · Gut · 52
PDF
The PHD1 oxygen sensor in health and disease
2018 · Kilian B. Kennel, Julius Burmeister, et al. · The Journal of Physiology · 34
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis
2025 · Dominic Denk, Mallika Ramakrishnan, et al. · Immunity · 25
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
2022 · Kilian B. Kennel, Julius Burmeister, et al. · JCI Insight · 10
PDF
Prolyl Hydroxylase Inhibition Mitigates Pouchitis
2019 · Jonathan M Harnoss, Jasper M Gebhardt, et al. · Inflammatory Bowel Diseases · 10
Data from Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
2024 · Henner F. Farin, Mohammed H. Mosa, et al. · 3
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer
2026 · Christoph Steup, Julian Dosch, et al. · The Journal of Pathology
Supplementary Tables 1-12 from Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2025 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Figures 1-12 from Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2025 · Henner F. Farin, Mohammed H. Mosa, et al.
PDF
Supplementary Figures 1-12 from Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
2024 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Figures 1-12 from Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
2024 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Tables 1-12 from Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
2024 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Tables 1-12 from Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses
2024 · Henner F. Farin, Mohammed H. Mosa, et al.
Data from Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2023 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Tables 1-12 from Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2023 · Henner F. Farin, Mohammed H. Mosa, et al.
Supplementary Figures 1-12 from Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2023 · Henner F. Farin, Mohammed H. Mosa, et al.
The HIF-prolyl hydroxylases have distinct and non-redundant biological roles in the pathogenesis of colitis-associated cancer
2023 · Jonathan Harnoss, Kilian Kennel, et al. · Physiology
Works count: 24
Citation count: 1,683
H-index: 10
I10-index: 12
Year
Topic
Type